Although rare, male breast cancer (MBC) remains a substantial cause for morbidity and
mortality in men. Based on age frequency distribution, age-specific incidence rate pattern …

Male breast cancer (MaBC) is a rare disease, accounting for less than 1% of malignancies in
men. For this reason, literature data on its clinicopathological characteristics are very …

Male breast cancer (MBC) is considered as a rare disease comprising about 1% of all breast
cancers. As compared to women breast cancer, MBC has some similarities and also some …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …

Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …

Significant advances have been made in the diagnosis and treatment of female breast
cancer, resulting in a decline in incidence and a global improvement in clinical outcome …

Breast cancer is one of the most commonly treated malignancies worldwide, but is rare in
males. Less than one percent of all breast cancers occur in men, and breast cancer …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Background Male breast cancer (MBC) is rare. Given the paucity of randomized trials,
treatment is generally extrapolated from female breast cancer guidelines. Methods This is a …